Canopy Growth Corp (CGC)
3.78
-0.16
(-4.06%)
USD |
NASDAQ |
Nov 14, 12:57
Canopy Growth Total Assets (Quarterly): 912.12M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 912.12M |
| June 30, 2024 | 939.06M |
| March 31, 2024 | 962.35M |
| December 31, 2023 | 1.025B |
| September 30, 2023 | 1.227B |
| June 30, 2023 | 1.653B |
| March 31, 2023 | 1.804B |
| December 31, 2022 | 2.225B |
| September 30, 2022 | 2.488B |
| June 30, 2022 | 2.730B |
| March 31, 2022 | 4.490B |
| December 31, 2021 | 4.948B |
| September 30, 2021 | 5.089B |
| June 30, 2021 | 5.618B |
| March 31, 2021 | 5.406B |
| December 31, 2020 | 4.948B |
| September 30, 2020 | 4.911B |
| June 30, 2020 | 5.012B |
| March 31, 2020 | 4.836B |
| December 31, 2019 | 6.160B |
| September 30, 2019 | 6.213B |
| June 30, 2019 | 6.586B |
| March 31, 2019 | 6.415B |
| December 31, 2018 | 6.344B |
| September 30, 2018 | 2.304B |
| Date | Value |
|---|---|
| June 30, 2018 | 1.593B |
| March 31, 2018 | 1.113B |
| December 31, 2017 | 870.89M |
| September 30, 2017 | 642.12M |
| June 30, 2017 | 571.80M |
| March 31, 2017 | 526.94M |
| December 31, 2016 | 208.17M |
| September 30, 2016 | 149.23M |
| June 30, 2016 | 117.67M |
| March 31, 2016 | 110.44M |
| December 31, 2015 | 107.77M |
| September 30, 2015 | 92.23M |
| June 30, 2015 | 40.08M |
| December 31, 2014 | 22.36M |
| September 30, 2014 | 22.72M |
| June 30, 2014 | 25.93M |
| March 31, 2014 | 13.09M |
| January 31, 2014 | 0.4158M |
| October 31, 2013 | 0.4778M |
| July 31, 2013 | 0.4928M |
| April 30, 2013 | 0.505M |
| January 31, 2013 | 0.5144M |
| October 31, 2012 | 0.5328M |
| July 31, 2012 | 0.5444M |
| April 30, 2012 | 0.5545M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
912.12M
Minimum
Sep 2024
6.160B
Maximum
Dec 2019
3.369B
Average
3.610B
Median
Total Assets (Quarterly) Benchmarks
| Tilray Brands Inc | 4.262B |
| Aurinia Pharmaceuticals Inc | 549.36M |
| Edesa Biotech Inc | 5.228M |
| Lexaria Bioscience Corp | 10.02M |
| Xenon Pharmaceuticals Inc | 884.01M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 534.89M |
| Shareholders Equity (Quarterly) | 377.23M |
| Debt to Equity Ratio | 1.087 |
| Current Ratio | 1.392 |
| Net Debt Paydown Yield | 16.74% |